PREPROPOSAL STATEMENT OF INQUIRY
HEALTH CARE AUTHORITY
[Filed November 3, 2020, 2:54 p.m.]
Subject of Possible Rule Making: WAC 182-51-0600 Manufacturers—Data and price reporting, and 182-51-0900 Data confidentiality; other related rules as appropriate.
Reasons Why Rules on this Subject may be Needed and What They Might Accomplish: Health care authority (HCA) is amending WAC 182-51-0600 to change the timeframe manufacturers have to report to HCA new covered drugs being introduced to market in Washington. HCA is also amending WAC 182-51-0900 to add the contents of the prescription drug pricing transparency program's nondisclosure agreement. During the course of this review, the agency may identify additional related changes that are required in order to improve clarity or update policy.
Other Federal and State Agencies that Regulate this Subject and the Process Coordinating the Rule with These Agencies: Not applicable.
Process for Developing New Rule: The agency welcomes the public to take part in developing this rule. If interested, contact the person identified below to receive an early rule draft to review. After the early review, the agency will send a notice of proposed rule making (CR-102) to everyone receiving this notice and anyone who requests a copy.
Interested parties can participate in the decision to adopt the new rule and formulation of the proposed rule before publication by contacting Jason Crabbe, Rulemaking Questions, P.O. Box 42716, Olympia, WA 98504-2716, phone 360-725-9563, fax 360-586-9727, telecommunication[s] relay service (TRS) 711, email firstname.lastname@example.org, website www.hca.wa.gov/about-hca/rulemaking; or Donna Sullivan, Program Questions, P.O. Box 45502, Olympia, WA 98504-5502, phone 360-725-1564, fax 360-586-9727, TRS 711, email email@example.com, website www.hca.wa.gov/about-hca/rulemaking.
November 3, 2020